
1 - 10 employees
Founded 2017
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
💰 $100M Private Equity Round on 2022-04
Healthcare • Biotechnology • Pharmaceuticals
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel monoclonal antibodies to treat severe autoimmune and inflammatory diseases. The company leverages advanced antibody engineering technologies to create next-generation complement therapeutics with improved selectivity and potency. Its lead program, DNTH103, is a monoclonal antibody targeting the classical complement pathway for conditions such as generalized Myasthenia Gravis, Multifocal Motor Neuropathy, and Chronic Inflammatory Demyelinating Polyneuropathy. Based in New York City and Waltham, Massachusetts, Dianthus aims to deliver transformative medicinal therapies by addressing unmet needs in autoimmune treatment.
🕒 August 4
Improve your chances of getting an interview by checking your resume score before you apply.

1 - 10 employees
Founded 2017
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
💰 $100M Private Equity Round on 2022-04
Healthcare • Biotechnology • Pharmaceuticals
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel monoclonal antibodies to treat severe autoimmune and inflammatory diseases. The company leverages advanced antibody engineering technologies to create next-generation complement therapeutics with improved selectivity and potency. Its lead program, DNTH103, is a monoclonal antibody targeting the classical complement pathway for conditions such as generalized Myasthenia Gravis, Multifocal Motor Neuropathy, and Chronic Inflammatory Demyelinating Polyneuropathy. Based in New York City and Waltham, Massachusetts, Dianthus aims to deliver transformative medicinal therapies by addressing unmet needs in autoimmune treatment.
• Develop and execute commercial insights strategy for DNTH212 and claseprubart across multiple autoimmune and rare disease indications • Generate actionable market insights, competitive intelligence, forecasting, and strategic recommendations for development and commercialization planning • Partner with cross-functional teams to shape development strategy, assess market opportunities, and support critical business decisions • Lead competitive intelligence for the DNTH212 program and provide timely information to the project team and Dianthus leadership • Develop plans to understand potential market dynamics, pipeline development, current treatment, and likely positioning of future treatments • Lead development of fact-based forecasting models for each indication • Build commercial narratives around claseprubart and DNTH212 for investors, patients, and physicians • Support lifecycle planning, indication prioritization, and portfolio strategy for both programs • Contribute to market insights development for claseprubart and help build the market insights function at Dianthus • Report to the Senior Director
• Bachelor’s degree is required • Substantial education in a field relevant to medicine • Advanced degree in life-sciences strongly preferred • Experience with rheumatology and/or neurology strongly preferred • Experience and proficiency analyzing and synthesizing data and information from multiple sources to create a clear and concise story • Strong communication skills and comfort presenting to executive leadership • Experience conducting market research, including development of surveys and study guides • Proficiency with MS Excel and experience building forecasts • Experience with claims data analysis and/or EHR analysis preferred • Experience conducting or moderating KOL interviews strongly preferred
Apply Now🕒 August 4
Associate Director leading risk-based monitoring and clinical data governance for ImmunityBio. Overseeing central surveillance systems supporting cancer and infectious disease therapies.
🕒 August 4
Senior Director leading healthcare consulting engagements, client portfolios, and clinical/technical advisory work for Premier. Selling large engagements and improving healthcare through technology-driven solutions.
🕒 August 4
Senior Director selling OneStudyTeam’s clinical-trial SaaS platform to biotech and pharma enterprises. Managing strategic accounts, growth plans, pipeline, demonstrations, and cross-sell opportunities remotely.
🕒 August 4
Regional operations leader overseeing ADESA’s U.S. auto auction network. Leading General Managers, strategic initiatives, and performance across approximately 10 auction sites.
🕒 August 4
Regional leader overseeing ADESA’s U.S. vehicle auction operations across approximately 10 sites. Driving strategic initiatives, performance, leadership development, and operational change across the region.